RBC Capital Maintains Outperform on Zimmer Biomet Holdings, Raises Price Target to $115

Benzinga · 5d ago
RBC Capital analyst Shagun Singh maintains Zimmer Biomet Holdings (NYSE:
ZBH) with a Outperform and raises the price target from $112 to $115.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.